AhR, ARNT, and CYP1A1 mRNA quantitation in cultured human embryonic palates exposed to TCDD and comparison with mouse palate in vivo and in culture

Toxicological Sciences

Volumn 47, Issue 1, 1999, Pages 62-75

  Abbott, B D ^a   Held, G A ^a   Wood, C R ^a   Buckalew, A R ^a   Brown, J G ^a,b   Schmid, J ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Ah receptor; ARNT; CYP1A1; Dioxin; Palate; Quantitative RT PCR

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CARRIER PROTEIN; ETHOXYRESORUFIN DEETHYLASE; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; CLEFT PALATE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN CULTURE; PALATE; SPECIES DIFFERENCE;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BASE SEQUENCE; CYTOCHROME P-450 CYP1A1; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; HUMANS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; ORGAN CULTURE TECHNIQUES; PALATE; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TERATOGENS; TETRACHLORODIBENZODIOXIN; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 0032906628     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/47.1.62     Document Type: Article

References (42)

1. Abbott, B. D., and Birnbaum, L. S. (1989). TCDD alters medial epithelial cell differentiation during palatogenesis. Toxicol. Appl. Pharmacol. 99, 276-286.
2. Abbott, B. D., and Birnbaum, L. S. (1990). TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicol. Appl. Pharmacol. 106, 418-432.
3. Abbott, B. D., and Birnbaum, L. S. (1991). TCDD exposure of human embryonic palatal shelves in organ culture alters the differentiation of medial epithelial cells. Teratology 43, 119-132.
4. Abbott, B. D., Birnbaum, L. S., and Diliberto, J. J. (1996). Rapid distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to embryonic tissues in C57BL/6N mice and correlation with palatal uptake in vitro. Toxicol. Appl. Pharmacol. 141, 256-263.
5. Abbott, B. D., Birnbaum, L. S., and Perdew, G. H. (1995). Developmental expression of two members of a new class of transcriptional factors. Part I: Expression of Ah receptor in the C57BL/6N mouse embryo. Dev. Dyn. 204, 133-143.
6. Abbott, B. D., and Buckalew, A. R. (1992). Embryonic palatal responses to teratogens in serum-free organ culture. Teratology 45, 369-382.
7. Abbott, B. D., Diliberto, J. J., and Birnbaum, L. S. (1989). TCDD alters embryonic palatal medial epithelial cell differentiation in vitro. Toxicol. Appl. Pharmacol. 100, 119-131.
8. Abbott, B. D., Perdew, G. H., and Birnbaum, L. S. (1994a). Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. Toxicol. Appl. Pharmacol. 126, 16-25.
9. Abbott, B. D., Perdew, G. H., Buckalew, A. R., and Birnbaum, L. S. (1994b). Interactive regulation of Ah and glucocorticoid receptors in the synergistic induction of cleft palate by TCDD and hydrocortisone. Toxicol. Appl. Pharmacol. 128, 138-150.
10. Abbott, B. D., and Probst, M. R. (1995). Developmental expression of two members of a new class of transcriptional factors. Part II: Expression of Ah receptor nuclear translocator (ARNT) in the C57BL/6N mouse embryo. Dev. Dyn. 204, 144-155.
11. Abbott, B. D., Probst, M. R., and Perdew, G. H. (1994c). Immunohistochemical double-staining for Ah receptor and ARNT in human embryonic palatal shelves. Teratology 50, 361-366.
12. Abbott, B. D., Probst, M. R., Perdew, G. H., and Buckalew, A. R. (1998). ARNT, glucocorticoid receptor, EGF receptor, EGF, TGFα, TGFβ1, TGFβ2, and TGFβ3 expression in huuman embryonic palate and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratology 58, 30-43.
13. Abbott, B. D., Schmid, J. E., Brown, J. G., Wood, C. R., White, R. D., Buckalew, A. R., and Held, G. A. (1999). RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol. Sci., 47, 76-85.
14. Birnbaum, L. S. (1995). The developmental effects of dioxins. Environ. Health. Persp. 103(Supp. 7), 89-95.
15. Couture, L. A., Abbott, B. D., and Birnbaum, L. S. (1990). A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Recent advances toward understanding the mechanism. Teratology 42, 619-627.
16. Dolwick, K. M., Schmidt, J. V., Carver, L. A., Swanson, H. I., and Bradfield, C. A. (1993). Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol. 44, 911-917.
17. Ema, M., Ohe, N., Suzuki, M., Mimura, J., Sogawa, K., Ikawa, S., and Fujii-Kuriyama, Y. (1994). Dioxin-binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. J. Biol. Chem. 269, 27337-27343.
18. 3-450. Gene 29, 281-292.
19. Hayashi, S., Watanabe, J., Nakachi, K., Eguchi, H., Gotoh, O., and Kawajiri, K. (1994). Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15, 801-806.
20. Hoffman, E. C., Reyes, H., Chu, F.-F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. (1991). Cloning of a factor required for activity of the Ah (Dioxin) receptor. Science 252, 954-958.
21. Holmes, J. L., and Pollenz, R. S. (1997). Determination of Aryl hydrocarbon receptor nuclear translocator protein concentration and subcellular localization in hepatic and nonhepatic cell culture lines: Development of quantitative Western blotting protocols for calculation of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein in total cell lysates. Mol. Pharmacol. 52, 202-211.
22. Jaiswal, A. K., Gonzalez, F. J., and Nebert, D. W. (1985). Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo-[a]pyrene metabolism. Nucleic Acids Res. 13, 4503-4520.
23. Juchau, M. R., Lee, Q. P., and Fantel, A. G. (1992). Xenobiotic biotransformation/bioactivation in organogenesis-stage conceptal tissues: Implications for embryotoxicity and teratogenesis. Drug Metab. Reviews 24, 195-238.
24. 3-450 cDNA nucleotide and amino acid sequences. J. Biol. Chem. 259, 10705-10713.
25. Manchester, D. K., Gordon, S. K., Golas, C. L., Roberts, E. A., and Okey, A. B. (1987). Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo(a)pyrene. Cancer Res. 47, 4861-4868.
26. Miller, M. S., Juchau, M. R., Guengerich, F. P., Nebert, D. W., and Raucy, J. L. (1996). Drug metabolic enzymes in developmental toxicology. Fund. Appl. Toxicol. 34, 165-175.
27. Omiecinski, C. J., Redlich, C. A., and Costa, P. (1990). Induction and developmental expression of cytochrome P4501A1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction. Cancer Res. 50, 4315-4321.
28. Perdew, G. H., and Hollenback, C. E. (1995). Evidence for two functionally distinct forms of the human Ah receptor. J. Biochem. Toxicol. 10, 95-102.
29. Poland, A., and Glover, E. (1980). 2,3,7,8-tetrachlorodibenzo-p-dioxin: Segregation of toxicity with the Ah locus. Mol. Pharmacol. 17, 86-94.
30. Pollenz, R. S., Santosteffano, M. J., Klett, E., Richardson, V. M., Necela, B., and Birnbaum, L. S. (1998). Female Sprague-Dawley rats exposed to a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibit sustained depletion of aryl hydrocarbon receptor protein in liver, spleen, thymus, and lung. Toxicol. Sci. 42, 117-128.
31. Pratt, R. M., Dencker, L., and Diewert, V. M. (1984). 2,3,7,8-tetrachlorod-ibenzo-p-dioxin-induced cleft palate in the mouse: evidence for alterations in palatal shelf fusion. Teratogen. Carcinogen. Mutagen. 4, 427-436.
32. Reyes, H., Reisz-Porszasz, S., and Hankinson, O. (1992). Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256, 1193-1195.
33. SAS Institute (1989). SAS/STAT User's Guide, vers. 6, 4th ed., vol. 2, SAS Institute, Cary, NC.
34. SAS Institute (1990). SAS Language: reference, vers. 6, 1st ed., SAS Institute, Cary, NC.
35. SAS Institute (1992). SAS Technical Report P-229, SAS/STAT Software: Changes and Enhancements, release 6.07, SAS Institute, Cary, NC.
36. Schecter, A., Startin, J., Wright, C., Päpke, O., Ball, M., and Lis, A. (1996). Concentrations of polychlorinated dibenzo-p-dioxins and dibenzofurans in human placental and fetal tissues from the U.S. and in placentas from Yu-Cheng exposed mothers. Chemosphere 32, 551-557.
37. Schmidt, J. V., and Bradfield, C. A. (1996). Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12, 55-89.
38. Vanden Heuvel, J. P., Clark, G. C., Thompson, C. L., McCoy, Z., Miller, C. R., Lucier, G. W., and Bell, D. A. (1993). CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carcinogenesis 14, 2003-2006.
39. Wang, X., Thomsen, J. S., Santostefano, M., Rosengren, R., Safe, S., and Perdew, G. H. (1995). Comparative properties of the nuclear aryl hydrocarbon (Ah) receptor complex from several human cell lines. European J. Pharmacol. 293, 191-205.
40. Whitlock, J. P., Jr., Okino, S. T., Dong, L., Ko, H. P., Clarke-Katzenberg, R., Ma, Q., and Li, H. (1996). Induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. FASEB J. 10, 809-818.
41. Yang, H.-Y. L., Namkung, M. J., and Juchau, M. R. (1995). Expression of functional cytochrome P4501A1 in human embryonic hepatic tissues during organogenesis. Biochem. Pharm. 49, 717-726.
42. Zimmerman, E. F. (1997). Palate. In: Handbook of Experimental Pharmacology 124/I: Drug toxicity in embryonic development I. (R. J. Kavlock, G. P. Daston, Eds.) pp. 183-208. Springer-Verlag, New York.